C
01228
CANbridge Pharmaceuticals
2.700
+0.710+35.68%Closed16:08 06/30 HKT
OPEN/PREV CLOSE2.050/1.990
TODAY RANGE1.950-2.700
VOL3.21M
MARKET CAP1.61B
52 WEEK RANGE0.270-3.500
AVG VOL (3M)704.39K
% TURNOVER0.54%
TURNOVER8.25M
P/E (TTM)97.826
% RANGE37.69%
EPS(TTM)0.028
P/E(FORWARD)-3.269
P/B-4.249
BVPS-0.635
DIVIDEND--
P/S29.064
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.61B
SHARES OUTSTANDING595.44M
NEXT EARNINGS--
FREE FLOAT595.44M
LOT SIZE1000
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·04/01 10:22
CANbridge Pharmaceuticals (SEHK:1228) Profit Swing To C¥59.2m Tests Bullish Narratives
Simply Wall St·12/19/2025 23:18
Individual investors are CANbridge Pharmaceuticals Inc.'s (HKG:1228) biggest owners and were hit after market cap dropped HK$138m
Reuters·12/08/2025 10:11
CANBRIDGE PHARMACEUTICALS - CAN 103 INCLUDED IN CHINA'S INNOVATIVE DRUG LIST
Reuters·12/04/2025 13:16
Canbridge Pharmaceuticals Inc. held extraordinary general meeting
Reuters·11/19/2025 08:48
Canbridge Pharmaceuticals Inc. Announces Date for Upcoming Extraordinary General Meeting
Reuters·11/17/2025 11:05
Canbridge Pharmaceuticals to Vote on Refreshment of General Mandate at Upcoming EGM
Simply Wall St·09/02/2025 23:06
CANbridge Pharmaceuticals First Half 2025 Earnings: EPS: CN¥0.14 (vs CN¥0.58 loss in 1H 2024)
Reuters·08/31/2025 10:05
CANBRIDGE PHARMACEUTICALS H1 REVENUE RMB 22.2 MILLION
Reuters·08/12/2025 00:43
HKEX - TRADING IN SHARES OF CANBRIDGE PHARMACEUTICALS INC. WILL BE HALTED AT 9:00 A.M. TODAY
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.